United States · FDA National Drug Code directory
Desvenlafaxine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63304-191_cd04a0b2-a7f2-4629-997f-af2a8e65f15b
- Product NDC
- 63304-191
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Desvenlafaxine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130305
- Source listing expiry
- 20261231
Source-listed ingredients
- DESVENLAFAXINE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-191-30) · 63304-191-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-191-90) · 63304-191-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →